Market Watch – Page 566 – Biotech Insider

All Posts in "Market Watch"

Slack stock gains after analyst bets service could ‘replace or severely displace email’ in a few years

Three analysts begin coverage of Slack with bullish ratings on Monday

by Editor — July 16, 2019 By Editor in Market Watch

U.K. and U.S. regulators see promise in bond market adoption of Libor alternatives

Regulators warn market participants not to add to Libor ‘hole’

by Editor — July 16, 2019 By Editor in Market Watch

U.S. manufacturers move production from China as tariff tensions continue

And companies that leave China don’t expect to move back

by Editor — July 15, 2019 By Editor in Market Watch

Visa or Mastercard—what’s the difference, anyway?

How these financial tools are similar, and what sets them apart

by Editor — July 15, 2019 By Editor in Market Watch

Asian markets recover after China’s GDP growth fails to meet already low expectations

Indexes in Hong Kong, Shanghai rise; Nikkei closed for holiday

by Editor — July 15, 2019 By Editor in Market Watch

This month the U.S. economy will have been growing for a record 121 months — what could cause a recession?

Federal Reserve fears trade policy ‘cross currents’ will end the party

by Editor — July 15, 2019 By Editor in Market Watch

Should investors prepare for a “shock and awe” campaign from the Fed?

Powell may look to take markets by surprise

by Editor — July 14, 2019 By Editor in Market Watch

Amazon is spending $700 million retraining workers, but critics say it should attend to other housekeeping duties first

‘Amazon is throwing money at a problem it created and somehow thinks that it deserves applause’

by Editor — July 14, 2019 By Editor in Market Watch

Investor who nailed the 1987 crash ditches stocks and bonds and here’s why

Critical information for the U.S. trading day

by Editor — July 14, 2019 By Editor in Market Watch

New technology requirement may ground more than 1 in 10 private jets in 2020

It can cost up to $200,000 to outfit planes with ADS-B Out surveillance technology as mandated beginning next year by regulators in U.S., Europe and elsewhere

by Editor — July 14, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.